Drug Discovery – Page 4

Exscientia Merges with Recursion to Form AI-Driven Drug Discovery Leader

8 months ago talkbio0Tagged AI, Artificial Intelligence, Drug Discovery, Exscientia, precision chemistry, Recursion, small molecule synthesis

Exscientia, Recursion, AI drug discovery, merger, precision chemistry, small molecule synthesis, biotech consolidation

GSK Partners with Flagship Pioneering to Develop 10 Novel Medicines and Vaccines

9 months ago talkbio0Tagged bioplatform companies, Drug Discovery, Flagship, Immunology, Partnership, Pfizer, Pioneering, Respiration Disorders, RNA, Messenger, SmithKline Beecham, Vaccines

GSK, Flagship Pioneering, drug discovery, vaccines, respiratory disease, immunology, bioplatform companies, mRNA vaccines, Pfizer, biotech partnership

EvolutionaryScale Secures $142M for AI-Driven Drug Discovery

10 months ago talkbio0Tagged Drug Development, Drug Discovery, EvolutionaryScale, Investments

EvolutionaryScale, AI-driven drug discovery, $142M investment, drug development, pharmaceuticals

Exscientia Streamlines Operations, Prioritizes AI-Driven Drug Discovery

11 months ago talkbio0Tagged AI-generated pipeline, Biotechnology, Drug Discovery, Drug Industry, Efficiency, Exscientia, operational, Staff

Exscientia, AI-generated pipeline, drug discovery, staff reduction, operational efficiency, biotechnology, pharmaceutical industry

Takeda Ventures into Molecular Glue Degraders with Degron Collaboration

11 months ago talkbio0Tagged Degron, Drug Discovery, molecular glue, pharmaceutical collaboration, Protein Degradation, Metabolic, Takeda

Takeda, Degron, molecular glue degraders, pharmaceutical collaboration, targeted protein degradation, drug discovery.

Revolutionizing Drug Discovery: Sanofi, OpenAI, and Formation Bio Join Forces

11 months ago talkbio0Tagged Anabolism, Artificial Intelligence, Bio, Drug Development, Drug Discovery, healthcare innovation, OpenAI, Partnership, sanofi

Sanofi, OpenAI, Formation Bio, AI, drug development, partnership, drug discovery, pharmaceuticals, artificial intelligence, healthcare innovation.

Exscientia, AI Biotech Firm, Announces Workforce Reduction Amidst Pipeline Changes and CEO Departure

11 months ago talkbio0Tagged AI, Artificial Intelligence, CEO, Drug Discovery, Drug Industry, Exscientia, firing, restructuring

Exscientia, AI biotech, workforce reduction, pipeline cut, CEO firing, restructuring, pharmaceutical industry, drug discovery

Revolutionizing Drug Discovery: The Evolution from Target-Selective Design to AI-Powered Polypharmacology

11 months ago talkbio0Tagged AI-enabled, Drug Discovery, Machine Learning, multi-target, Polypharmacology, Precision Medicine, Systems Biology, Target-Selective Design

Drug Discovery, Target-Selective Design, AI-Enabled Polypharmacology, Machine Learning, Systems Biology, Multi-Target Drugs, Personalized Medicine.

Revolutionizing Protein Design: Nabla Bio Secures $26M for AI-Driven Pharmaceutical Solutions

11 months ago talkbio0Tagged Artificial Intelligence, Biotechnology, Drug Discovery, genAI protein design, healthcare innovation, Nabla Bio, pharmaceutical partners, Protein Engineering

Nabla Bio, genAI protein design, funding, pharmaceutical partners, biotechnology, protein engineering, drug discovery, artificial intelligence, healthcare innovation.

Revolutionizing Pharmaceuticals: Nabla Bio Secures $26M for AI-Powered Protein Design

11 months ago talkbio0Tagged Artificial Intelligence, Biotechnology, Drug Discovery, generative, Nabla Bio, pharmaceutical partners, protein design

Nabla Bio, generative AI, protein design, funding, pharmaceutical partners, biotechnology, drug discovery.